Actively Recruiting

Phase 2
Phase 3
Age: 18Years +
All Genders
NCT06902805

Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis.

Led by Assistance Publique - Hôpitaux de Paris · Updated on 2026-04-03

120

Participants Needed

1

Research Sites

152 weeks

Total Duration

On this page

Sponsors

A

Assistance Publique - Hôpitaux de Paris

Lead Sponsor

U

URC-CIC Paris Descartes Necker Cochin

Collaborating Sponsor

AI-Summary

What this Trial Is About

The main objective of this study will be to compare the effects of 2 intra-articular injections of onabotulinumtoxinA with those of 1 intra-articular injection of onabotulinumtoxinA and 1 of normal saline and those of 2 intra-articular injections of normal saline on base-of-thumb pain at 6 months after the first injection.

CONDITIONS

Official Title

Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals aged at least 18 years
  • Pain intensity of at least 30 on a self-administered 11-point pain numeric rating scale
  • Pain involving the base of the thumb
  • X-ray evidence of trapezometacarpal osteoarthritis with at least two of the following: osteophytes, joint space narrowing, subchondral bone sclerosis, or subchondral cysts
  • Meeting 1990 ACR classification criteria for hand osteoarthritis adapted to trapezometacarpal osteoarthritis
  • Ability to give written informed consent before participation
  • Affiliation with a mode of social security (profit or being entitled)
  • Negative pregnancy test in women of childbearing potential
Not Eligible

You will not qualify if you...

  • Secondary osteoarthritis
  • History of thumb surgery, inflammatory or crystal-associated rheumatic disease, or epilepsy
  • Uncontrolled dysphagia, pneumonia, cardiovascular diseases, or signs of neuromuscular transmission disorders
  • Contraindication to onabotulinumtoxinA
  • Neurological disorders involving the hands other than carpal tunnel syndrome
  • Collagen disorders involving the hands
  • Osteoarthritis mainly at the scaphotrapezial joint on x-ray
  • Bilateral trapezometacarpal osteoarthritis without a dominant painful side
  • Hand or wrist trauma within the last 2 months
  • Intra-articular treatments within the last 2 months
  • Use of intramuscular, intravenous, or oral corticosteroids within the last 2 months
  • Protected adults including those under court guardianship
  • Pregnant or breastfeeding women; lack of contraception in women of childbearing potential
  • Participation in another investigational therapeutic study
  • Inability to speak or read French

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Assistance Publique - Hôpitaux de Paris, Service de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis du Pr François Rannou, Hôpital Cochin

Paris, Île-de-France Region, France, 75014

Actively Recruiting

Loading map...

Research Team

C

Christelle NGUYEN, MD, PhD

CONTACT

L

Laetitia PEAUDECERF, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here